164 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference http://www.zacks.com/stock/news/288624/pharma-stock-roundup-novo-nordisk-reveals-bid-to-acquire-ablynx-pfizer-others-at-healthcare-conference?cid=CS-ZC-FT-288624 Jan 12, 2018 - Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.
Why is Novo Nordisk Stock Up More Than 50% in Past Year? http://www.zacks.com/stock/news/288483/why-is-novo-nordisk-stock-up-more-than-50-in-past-year?cid=CS-ZC-FT-288483 Jan 11, 2018 - We take a look at the factors that led to the rise in Novo Nordisk's (NVO) share price in the past year.
Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know https://www.fool.com/investing/2018/01/10/eli-lilly-co-at-j-p-morgan-5-things-investors-will.aspx?source=iedfolrf0000001 Jan 10, 2018 - What's Lilly's next stage of growth? CEO Dave Ricks answered this question and more at the J.P. Morgan Healthcare Conference.
Novo Nordisk's Ozempic Gets Canadian Approval for Diabetes http://www.zacks.com/stock/news/288414/novo-nordisks-ozempic-gets-canadian-approval-for-diabetes?cid=CS-ZC-FT-288414 Jan 10, 2018 - Novo Nordisk (NVO) announced that Health Canada has approved Ozempic to improve glycemic control in adults with type II diabetes mellitus.
Novo Nordisk Confirms Bid for Ablynx But Faces Rejection http://www.zacks.com/stock/news/288271/novo-nordisk-confirms-bid-for-ablynx-but-faces-rejection?cid=CS-ZC-FT-288271 Jan 09, 2018 - Novo Nordisk (NVO) confirmed its revised offer made on Dec 22, to acquire Ablynx NV for $3.1 billion.
5 Biggest New Drugs of 2018 -- and How You Can Profit From Their Makers https://www.fool.com/investing/2018/01/07/5-biggest-new-drugs-of-2018-and-how-you-can-profit.aspx?source=iedfolrf0000001 Jan 07, 2018 - These new drugs could make billions of dollars for big drugmakers. And they could make you money, too.
3 Large-Cap Pharma Stocks to Watch Out for This New Year http://www.zacks.com/stock/news/287868/3-large-cap-pharma-stocks-to-watch-out-for-this-new-year?cid=CS-ZC-FT-287868 Jan 04, 2018 - We take a look at a few Large Cap drug stocks with a favorable combination of Zacks Rank and VGM Score. The stocks are poised to carry on their bull run this year too.
Orexigen Struggles as Contrave Commercialization Costs Rise http://www.zacks.com/stock/news/287853/orexigen-struggles-as-contrave-commercialization-costs-rise?cid=CS-ZC-FT-287853 Jan 04, 2018 - Orexigen (OREX) hurt by higher commercialization costs related to Contrave.
Can Merck Regain its Mojo in 2018 After an Unimpressive '17? http://www.zacks.com/stock/news/287654/can-merck-regain-its-mojo-in-2018-after-an-unimpressive-17?cid=CS-ZC-FT-287654 Jan 03, 2018 - Merck's (MRK) shares declined in 2017 against an increase witnessed by the large-cap pharma industry. It remains to be seen if the company regains momentum in 2018.
5 Reasons to Invest in Novo Nordisk (NVO) Stock Right Now http://www.zacks.com/stock/news/287540/5-reasons-to-invest-in-novo-nordisk-nvo-stock-right-now?cid=CS-ZC-FT-287540 Jan 02, 2018 - Let's take a look at few factors that help in determining if Novo Nordisk (NVO) will be a good investment in 2018.

Pages: 1...56789101112131415...17

<<<Page 10>